Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Infant Bacterial Therapeutics AB (publ)
  6. Company
    IBT B   SE0008015259

INFANT BACTERIAL THERAPEUTICS AB (PUBL)

(IBT B)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
Business Summary
Infant Bacterial Therapeutics AB is a Sweden-based company, which is primarily involved in the pharmaceutical industry. The Company develops drugs that meet the needs of the premature infant. The CompanyÔÇÖs focus is on clinical development of IBP-9414, a drug candidate containing Lactobacillus reuteri, in the prevention of necrotizing enterocolitis (NEC), a fatal disease that affects premature infants.
Managers
Name Title Age Since
Staffan Str÷mberg, Dr. Chief Executive Officer 53 2013
Marie-Louise Alamaa Chief Financial Officer - 2021
Eamonn Connolly, Dr. Chief Scientific Officer 63 2013
Jonas Rastad, Dr. Chief Medical Officer 70 -
Erik Anders Kronstr÷m Chief Operating Officer 53 2018
Margareta Hagman Independent Director 54 2015
Eva IdÚn Independent Director 54 2017
Anthon Jahreskog Independent Director 40 2017
Kristina Sj÷blom Nygren, Dr. Independent Director 59 2018
Agneta Heierson, Dr. Vice President-Clinical Development - -
Members of the board
Name Title Age Since
Peter Michael Rothschild Chairman 70 2011
Margareta Hagman Independent Director 54 2015
Eva IdÚn Independent Director 54 2017
Anthon Jahreskog Independent Director 40 2017
Kristina Sj÷blom Nygren, Dr. Independent Director 59 2018
Robert Molander Director 55 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 10,848,448 10,018,567 92.4% 0 0.0% 89.2%
Stock B 10 377,736 0 0.0% 0 0.0%
Shareholders
NameEquities%
Fjńrde AP-fonden 1,112,919 10.3%
Dinkelspiel Family 1,106,452 10.2%
Swedbank Robur Fonder AB 579,172 5.34%
Handelsbanken Fonder AB 555,133 5.12%
Annwall & Rothschild Investments AB 510,478 4.71%
Tredje AP-fonden 507,064 4.67%
AMF Fonder AB 501,585 4.62%
Unionen 447,196 4.12%
Norges Bank Investment Management 328,532 3.03%
David Dangoor 283,501 2.61%
Company contact information
Infant Bacterial Therapeutics AB
Bryggargatan 10
Stockholm 111 21

Phone : +46.8.410.145.55
Web : http://www.ibtherapeutics.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Infant Bacterial Therapeutics AB (publ)